Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prenatal Nutritional Physiological Phenomena | 2 | 2021 | 156 | 1.370 |
Why?
|
Gestational Age | 5 | 2021 | 3308 | 1.330 |
Why?
|
Body Height | 5 | 2022 | 1641 | 1.220 |
Why?
|
Growth Disorders | 3 | 2022 | 663 | 1.190 |
Why?
|
Adolescent Development | 1 | 2021 | 286 | 0.680 |
Why?
|
Child Development | 3 | 2020 | 2279 | 0.660 |
Why?
|
Dietary Supplements | 9 | 2022 | 2955 | 0.620 |
Why?
|
Birth Weight | 2 | 2021 | 1897 | 0.600 |
Why?
|
Intelligence | 1 | 2021 | 931 | 0.590 |
Why?
|
Cholecalciferol | 6 | 2016 | 433 | 0.590 |
Why?
|
Data Mining | 1 | 2020 | 548 | 0.570 |
Why?
|
Anthropometry | 5 | 2022 | 1456 | 0.550 |
Why?
|
Vitamin D Deficiency | 5 | 2015 | 1334 | 0.520 |
Why?
|
Nutritional Status | 2 | 2020 | 1554 | 0.500 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2015 | 365 | 0.480 |
Why?
|
Executive Function | 1 | 2021 | 1263 | 0.470 |
Why?
|
Prenatal Care | 2 | 2014 | 1003 | 0.400 |
Why?
|
Pregnancy Trimester, Third | 6 | 2021 | 572 | 0.360 |
Why?
|
Tanzania | 5 | 2022 | 1123 | 0.340 |
Why?
|
Infant, Premature | 1 | 2015 | 2034 | 0.300 |
Why?
|
Vitamin D | 4 | 2015 | 3064 | 0.290 |
Why?
|
Public Health | 1 | 2018 | 2357 | 0.280 |
Why?
|
Pregnancy | 15 | 2022 | 25703 | 0.270 |
Why?
|
Vitamins | 4 | 2022 | 1363 | 0.260 |
Why?
|
Growth Charts | 1 | 2022 | 61 | 0.230 |
Why?
|
Premature Birth | 2 | 2022 | 1307 | 0.230 |
Why?
|
Infant, Small for Gestational Age | 2 | 2022 | 434 | 0.220 |
Why?
|
Infant | 9 | 2022 | 33918 | 0.220 |
Why?
|
Bangladesh | 4 | 2015 | 664 | 0.220 |
Why?
|
Body Weight | 3 | 2022 | 4804 | 0.200 |
Why?
|
Intelligence Tests | 1 | 2021 | 522 | 0.200 |
Why?
|
Pregnancy Complications | 4 | 2022 | 2839 | 0.190 |
Why?
|
Infant, Newborn | 9 | 2022 | 23953 | 0.190 |
Why?
|
Micronutrients | 1 | 2021 | 343 | 0.180 |
Why?
|
Growth and Development | 1 | 2018 | 49 | 0.180 |
Why?
|
Sulfones | 1 | 2021 | 452 | 0.180 |
Why?
|
Education | 1 | 2021 | 554 | 0.180 |
Why?
|
Lactones | 1 | 2021 | 349 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3995 | 0.170 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2021 | 352 | 0.170 |
Why?
|
Diet | 1 | 2013 | 7351 | 0.140 |
Why?
|
Cathelicidins | 1 | 2014 | 34 | 0.140 |
Why?
|
Folic Acid | 1 | 2021 | 1232 | 0.140 |
Why?
|
Anthelmintics | 1 | 2013 | 54 | 0.130 |
Why?
|
Leptin | 1 | 2021 | 1604 | 0.130 |
Why?
|
Income | 1 | 2021 | 1795 | 0.120 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1414 | 0.120 |
Why?
|
Linear Models | 2 | 2021 | 6088 | 0.120 |
Why?
|
Female | 19 | 2022 | 375459 | 0.120 |
Why?
|
Developing Countries | 2 | 2021 | 2732 | 0.120 |
Why?
|
Malnutrition | 1 | 2018 | 601 | 0.110 |
Why?
|
Kenya | 1 | 2013 | 507 | 0.110 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7933 | 0.110 |
Why?
|
Growth | 1 | 2013 | 435 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 9337 | 0.110 |
Why?
|
Geographic Information Systems | 1 | 2013 | 276 | 0.110 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 393 | 0.110 |
Why?
|
Humans | 23 | 2022 | 686663 | 0.100 |
Why?
|
Nutrition Assessment | 1 | 2013 | 741 | 0.100 |
Why?
|
World Health Organization | 1 | 2015 | 1220 | 0.100 |
Why?
|
Models, Theoretical | 1 | 2021 | 3621 | 0.090 |
Why?
|
Child | 6 | 2022 | 71361 | 0.090 |
Why?
|
Office Visits | 1 | 2013 | 624 | 0.090 |
Why?
|
Phagocytosis | 1 | 2014 | 1582 | 0.090 |
Why?
|
Calcium | 3 | 2021 | 5696 | 0.090 |
Why?
|
Reference Values | 1 | 2015 | 5134 | 0.090 |
Why?
|
Child, Preschool | 5 | 2022 | 41159 | 0.090 |
Why?
|
Fetal Blood | 4 | 2014 | 1370 | 0.080 |
Why?
|
Fetus | 1 | 2014 | 1778 | 0.080 |
Why?
|
Antimalarials | 1 | 2013 | 835 | 0.080 |
Why?
|
Body Mass Index | 2 | 2022 | 12323 | 0.080 |
Why?
|
Mothers | 1 | 2015 | 1978 | 0.070 |
Why?
|
Research Design | 1 | 2021 | 5835 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2014 | 1477 | 0.070 |
Why?
|
Anemia | 1 | 2013 | 1357 | 0.070 |
Why?
|
Malaria | 1 | 2013 | 1037 | 0.070 |
Why?
|
Cohort Studies | 3 | 2021 | 38732 | 0.060 |
Why?
|
Double-Blind Method | 5 | 2016 | 11866 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 19295 | 0.060 |
Why?
|
Male | 6 | 2022 | 352465 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2371 | 0.060 |
Why?
|
Burkina Faso | 1 | 2022 | 86 | 0.060 |
Why?
|
India | 2 | 2021 | 2196 | 0.060 |
Why?
|
Adolescent | 5 | 2022 | 84957 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 21640 | 0.050 |
Why?
|
Middle East | 1 | 2020 | 194 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13500 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 49071 | 0.050 |
Why?
|
Databases, Factual | 1 | 2015 | 7865 | 0.050 |
Why?
|
Stillbirth | 1 | 2021 | 270 | 0.050 |
Why?
|
Macrophages | 1 | 2014 | 5748 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2013 | 2912 | 0.050 |
Why?
|
Pregnancy Trimester, Second | 1 | 2021 | 707 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12734 | 0.050 |
Why?
|
Young Adult | 5 | 2022 | 56052 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 648 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2022 | 2529 | 0.040 |
Why?
|
Pregnant Women | 1 | 2022 | 412 | 0.040 |
Why?
|
Biomedical Research | 1 | 2013 | 3285 | 0.040 |
Why?
|
Adult | 8 | 2022 | 211400 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 5182 | 0.040 |
Why?
|
Hypercalciuria | 1 | 2014 | 44 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3277 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13444 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2014 | 386 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2014 | 422 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 11616 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2014 | 488 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2014 | 589 | 0.030 |
Why?
|
Serum Albumin | 1 | 2013 | 688 | 0.030 |
Why?
|
Creatinine | 1 | 2013 | 1844 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1124 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3975 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 1841 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 5582 | 0.020 |
Why?
|
Homeostasis | 1 | 2014 | 3297 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2014 | 2892 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 20620 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 14744 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 11700 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 42271 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39737 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 69278 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 60991 | 0.010 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_